Mineralys Therapeutics, Inc. (MLYS)
NASDAQ·Healthcare·Biotechnology
$26.49
-1.60%
Mkt Cap $2.38B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$43.00
Range $30.00 – $56.00
Implied Upside
+62.3%
Consensus $43.00 vs current $26.49
NASDAQ·Healthcare·Biotechnology
$26.49
-1.60%
Mkt Cap $2.38B
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$43.00
Range $30.00 – $56.00
+62.3%
Consensus $43.00 vs current $26.49